Schedule 13G ownership disclosure

IMMUNOGEN INC

Security class unavailable · CUSIP: 45253H101

Event date: 2017-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,966,000
Percent of class
4.5400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-014297
Form type
SC 13G/A
Filer
ImmunoGen, Inc.
CIK
CIK 855654
Filed
Mar 06, 2017
Reporting period
Feb 28, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub